Zobrazeno 1 - 10
of 32
pro vyhledávání: '"van Dyk, Madelé"'
Publikováno v:
In Journal of Chromatography B 15 October 2016 1033-1034:17-26
Autor:
van Leuven, Jason, Evans, Simon, Kichenadasse, Ganessan, Steeghs, Neeltje, Bonevski, Billie, Mikus, Gerd, van Dyk, Madelé
Publikováno v:
Cancers; Jul2023, Vol. 15 Issue 13, p3293, 11p
Autor:
Hopkins, Ashley M., Sorich, Michael J., McLachlan, Andrew J., Karapetis, Christos S., Miners, John O., van Dyk, Madelé, Rowland, Andrew
Publikováno v:
JCO Precision Oncology; 2/14/2023, Vol. 7, p1-10, 10p
Autor:
Michelet, Robin, Ursino, Moreno, Boulet, Sandrine, Franck, Sebastian, Casilag, Fiordiligie, Baldry, Mara, Rolff, Jens, van Dyk, Madelé, Wicha, Sebastian, Sirard, Jean-Claude, Comets, Emmanuelle, Zohar, Sarah, Kloft, Charlotte
Publikováno v:
Pharmaceutics
Pharmaceutics, 2021, 13 (5), pp.601. ⟨10.3390/pharmaceutics13050601⟩
Pharmaceutics, MDPI, 2021, 13 (5), pp.601. ⟨10.3390/pharmaceutics13050601⟩
Volume 13
Issue 5
Pharmaceutics, Vol 13, Iss 601, p 601 (2021)
Pharmaceutics, 2021, 13 (5), pp.601. ⟨10.3390/pharmaceutics13050601⟩
Pharmaceutics, MDPI, 2021, 13 (5), pp.601. ⟨10.3390/pharmaceutics13050601⟩
Volume 13
Issue 5
Pharmaceutics, Vol 13, Iss 601, p 601 (2021)
International audience; The treatment of respiratory tract infections is threatened by the emergence of bacterial resistance. Immunomodulatory drugs, which enhance airway innate immune defenses, may improve therapeutic outcome. In this concept paper,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::0f3eced2285c88bd0176ee44f3c043fc
https://hal.sorbonne-universite.fr/hal-03215662
https://hal.sorbonne-universite.fr/hal-03215662
Autor:
Ziesenitz, Victoria C., Welzel, Tatjana, van Dyk, Madelé, Saur, Patrick, Gorenflo, Matthias, van den Anker, Johannes N.
Publikováno v:
Pediatric Drugs; Nov2022, Vol. 24 Issue 6, p603-655, 53p
Autor:
Rowland, Angela, van Dyk, Madelé, Warncken, David, Mangoni, Arduino A., Sorich, Michael J., Rowland, Andrew
AIM: To evaluate the capacity for modafinil to be a perpetrator of metabolic drug–drug interactions by altering cytochrome P450 activity following a single dose and dosing to steady state. METHODS: A single centre, open label, single sequence cockt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bc89e349089928955f6a9aa0346457cf
https://europepmc.org/articles/PMC5809348/
https://europepmc.org/articles/PMC5809348/
Autor:
Mueller-Schoell, Anna, Groenland, Stefanie L., Scherf-Clavel, Oliver, van Dyk, Madelé, Huisinga, Wilhelm, Michelet, Robin, Jaehde, Ulrich, Steeghs, Neeltje, Huitema, Alwin D.R., Kloft, Charlotte
Publikováno v:
European Journal of Clinical Pharmacology; Apr2021, Vol. 77 Issue 4, p441-464, 24p, 1 Chart
Autor:
van Dyk, Madelé, Kapetas, Asha J., Hopkins, Ashley M., Rodrigues, A. David, Vourvahis, Manoli, Sorich, Michael J., Rowland, Andrew
Publikováno v:
Frontiers in Pharmacology; 9/27/2019, p1-11, 11p
Autor:
van Dyk, Madelé, Miners, John O., Marshall, Jean-Claude, Wood, Linda S., Hopkins, Ashley, Sorich, Michael J., Rowland, Andrew
Publikováno v:
European Journal of Clinical Pharmacology; Sep2019, Vol. 75 Issue 9, p1211-1218, 8p, 4 Charts, 1 Graph
Publikováno v:
European Journal of Clinical Pharmacology; Jul2018, Vol. 74 Issue 7, p913-920, 8p, 3 Charts, 2 Graphs